Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$42.25 - $53.56 $3.88 Million - $4.92 Million
-91,834 Reduced 26.72%
251,858 $10.6 Million
Q2 2024

Jul 29, 2024

SELL
$41.71 - $52.9 $2.79 Million - $3.53 Million
-66,796 Reduced 16.27%
343,692 $15.8 Million
Q1 2024

Apr 29, 2024

BUY
$32.52 - $52.33 $5.07 Million - $8.16 Million
155,871 Added 61.22%
410,488 $21.4 Million
Q4 2023

Feb 07, 2024

SELL
$30.85 - $37.09 $205,923 - $247,575
-6,675 Reduced 2.55%
254,617 $9.07 Million
Q3 2023

Nov 02, 2023

SELL
$31.69 - $39.25 $502,159 - $621,955
-15,846 Reduced 5.72%
261,292 $8.76 Million
Q2 2023

Aug 07, 2023

SELL
$29.0 - $38.37 $428,620 - $567,108
-14,780 Reduced 5.06%
277,138 $10.4 Million
Q1 2023

May 09, 2023

SELL
$23.85 - $31.34 $150,517 - $197,786
-6,311 Reduced 2.12%
291,918 $8.56 Million
Q4 2022

Feb 09, 2023

BUY
$17.65 - $27.37 $5,524 - $8,566
313 Added 0.11%
298,229 $7.86 Million
Q3 2022

Nov 09, 2022

SELL
$22.62 - $32.54 $63,788 - $91,762
-2,820 Reduced 0.94%
297,916 $6.91 Million
Q2 2022

Aug 10, 2022

SELL
$22.88 - $39.45 $1.07 Million - $1.84 Million
-46,709 Reduced 13.44%
300,736 $7.57 Million
Q1 2022

May 09, 2022

SELL
$31.69 - $43.29 $481,117 - $657,228
-15,182 Reduced 4.19%
347,445 $13.3 Million
Q4 2021

Feb 09, 2022

SELL
$35.2 - $52.6 $1.58 Million - $2.36 Million
-44,916 Reduced 11.02%
362,627 $14.3 Million
Q3 2021

Nov 09, 2021

SELL
$46.35 - $59.75 $761,484 - $981,632
-16,429 Reduced 3.88%
407,543 $19.9 Million
Q2 2021

Aug 10, 2021

BUY
$47.2 - $67.81 $3.14 Million - $4.52 Million
66,629 Added 18.65%
423,972 $22.3 Million
Q1 2021

May 10, 2021

BUY
$30.93 - $59.48 $10.4 Million - $20.1 Million
337,362 Added 1688.41%
357,343 $19.9 Million
Q4 2020

Feb 08, 2021

BUY
$18.53 - $31.5 $370,247 - $629,401
19,981 New
19,981 $617,000
Q4 2019

Feb 05, 2020

SELL
$13.77 - $19.2 $482,610 - $672,921
-35,048 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$14.93 - $19.83 $26,769 - $35,555
1,793 Added 5.39%
35,048 $531,000
Q2 2019

Aug 12, 2019

BUY
$15.01 - $18.89 $175,301 - $220,616
11,679 Added 54.13%
33,255 $628,000
Q1 2019

May 10, 2019

BUY
$16.23 - $20.29 $1,493 - $1,866
92 Added 0.43%
21,576 $378,000
Q4 2018

Feb 14, 2019

BUY
$10.77 - $18.44 $25,438 - $43,555
2,362 Added 12.35%
21,484 $374,000
Q3 2018

Nov 14, 2018

BUY
$9.1 - $14.8 $3,412 - $5,550
375 Added 2.0%
19,122 $271,000
Q2 2018

Aug 13, 2018

BUY
$9.6 - $14.6 $179,971 - $273,706
18,747 New
18,747 $0

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.